Wasserman Chad J's Form 4 filing
HCA Healthcare, Inc. (HCA) · filed Mar 20, 2024
- Accession no.
- 0001209191-24-004999
- Filed
- Mar 20, 2024
- Trade date
- Mar 18-20, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $400.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wasserman Chad JCIK 0002010252 | Officer (SVP and CIO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Common Stock | MOption exerciseAcquired | +2,100 | $101.16 | +$212,436 | 4,020.31 | Direct | |
| Mar 18, 2024 | Common Stock | FTax withholdingDisposed | −1,224 | $327.17 | −$400,456.08 | 2,796.31 | Direct | |
| Mar 18, 2024 | Common Stock | SSaleDisposed | −344 | $321.97 | −$110,757.68 | 2,452.31 | Direct | |
| Mar 20, 2024 | Common Stock | SSaleDisposed | −876 | $330.25 | −$289,299 | 1,576.31 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 18, 2024 | Common Stock | MOption exerciseDisposed | −2,100 | $0.00 | $0 | 4,190 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.